Amy GilesIncreasing Engagement
David LinetskyPoint-of-Care Marketing
Pat PurcellMeeting Engagement
Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
Brenda SnowAuthentic Patient Voice
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Stacey GandlerBrand Nourishment
Matt TurnerPatient Affordability
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
Investigational therapy crizanlizumab (SEG101, formerly SelG1) approximately doubled the time to first on-treatment sickle ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email